The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

UBE2V1  -  ubiquitin-conjugating enzyme E2 variant 1

Homo sapiens

Synonyms: CIR1, CROC-1, CROC1, P/OKcl.19, TRAF6-regulated IKK activator 1 beta Uev1A, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of UBE2V1

  • FN, BBC1, and UEV-1 localize to regions of chromosomal aberration (2q3.4, 16q24.3, and 20q13.2, respectively) associated with advanced prostate cancer and thus may be highly relevant to disease progression [1].
  • In this report, we show that constitutive high-level expression of UEV1A alone in cultured human cells was sufficient to cause a significant increase in NF-kappaB activity as well as the expression of its target anti-apoptotic protein, Bcl-2 (B-cell leukemia/lymphoma 2) [2].
 

High impact information on UBE2V1

  • Here we report the crystal structure of a complex between hMms2 (Uev1) and hUbc13 at 1.85 A resolution and a structure of free hMms2 at 1.9 A resolution [3].
  • Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells [4].
  • Upstream of the ESX promoter region in this genomic fragment lies the terminal exon of a newly identified gene that encodes a ubiquitin-conjugating enzyme variant, UEV-1 [5].
  • The TSG101B isoform lacks the leucine zipper near the C-terminus, a transcriptional repressor domain, and retains most of the N-terminal region which has homology to E2 ubiquitin regulatory enzymes and the CROC-1 transcriptional regulator [6].
  • A 5-6-fold elevation in CIR1/CROC1 expression and a 2-3-fold elevation in CIR2 expression were observed in SV40-transformed human embryonic kidney cells immediately following proliferative crisis, suggesting a potential role for these genes in immortalization [7].
 

Biological context of UBE2V1

  • These results are compatible with induction of CIR1/CROC1 being an early event in the acquisition of immortality and with a role for this gene in the immortal phenotype of tumor cells [7].
  • Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumor-derived human cell lines [7].
  • The CROC-1 gene was isolated by its ability to transactivate c- fos expression in cell culture through a tandem repeat enhancer sequence [8].
  • The hMMS2 and CROC-1 genes are able to functionally complement the yeast mms2 defects with regard to sensitivity to DNA damaging agents and spontaneous mutagenesis [8].
  • DNA sequencing revealed the first plasmid, denoted CROC-1, to contain a 1.8-kb cDNA encoding a 16.5-kDa nuclear protein possessing a bipartite structure comprised an amino-terminal acidic domain and a carboxy-terminal basic domain, and displaying partial homology to the HMG domain of the TAF(II)250 transcription cofactor [9].
 

Anatomical context of UBE2V1

  • Expression of CIR1/CROC1 was found to be elevated also in a variety of immortal human tumor-derived cell lines, as compared to their normal tissue counterparts [7].
  • Unlike CROC-1 , whose transcript appears to be elevated in all tumor cell lines examined, the hMMS2 transcript is only elevated in some tumor cell lines [8].
  • We also show that the mutant phenotype is fully complemented by expression of the human UEV-1A cDNA and we propose that UEV-1 proteins could also have a role in protecting higher eukaryotic cells from DNA damaging agents [10].
  • 5. It is suggested that A23187 causes the release of Ca2+ from the S.R. by a mechanism that differs from both excitation and the CROC; the resultant rise in [Ca2+]i again causes myofibril degradation [11].
  • Cir1 also controls the known major virulence factors of the pathogen including the capsule, the formation of the anti-oxidant melanin in the cell wall, and the ability to grow at host body temperature [12].
 

Associations of UBE2V1 with chemical compounds

  • 3. It is argued that caffeine causes a Ca2+-induced release of Ca2+ (the CROC) from the S.R. and that the consequent rise in [Ca2+]i promotes the ultrastructural damage observed [11].
 

Other interactions of UBE2V1

 

Analytical, diagnostic and therapeutic context of UBE2V1

  • The sequence analysis of two cDNA indicates open reading frames which show significant similarities to known proteins involved in mechanisms of regulation: 1) nifR3, an element of the nitrogen regulatory system in bacteria and 2) CROC-1, a newly identified human transcription factor [13].

References

  1. Differentially expressed genes in hormone refractory prostate cancer: association with chromosomal regions involved with genetic aberrations. Stubbs, A.P., Abel, P.D., Golding, M., Bhangal, G., Wang, Q., Waxman, J., Stamp, G.W., Lalani, E.N. Am. J. Pathol. (1999) [Pubmed]
  2. Uev1A, a ubiquitin conjugating enzyme variant, inhibits stress-induced apoptosis through NF-kappaB activation. Syed, N.A., Andersen, P.L., Warrington, R.C., Xiao, W. Apoptosis (2006) [Pubmed]
  3. Crystal structure of the human ubiquitin conjugating enzyme complex, hMms2-hUbc13. Moraes, T.F., Edwards, R.A., McKenna, S., Pastushok, L., Xiao, W., Glover, J.N., Ellison, M.J. Nat. Struct. Biol. (2001) [Pubmed]
  4. Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells. Sancho, E., Vilá, M.R., Sánchez-Pulido, L., Lozano, J.J., Paciucci, R., Nadal, M., Fox, M., Harvey, C., Bercovich, B., Loukili, N., Ciechanover, A., Lin, S.L., Sanz, F., Estivill, X., Valencia, A., Thomson, T.M. Mol. Cell. Biol. (1998) [Pubmed]
  5. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP). Chang, C.H., Scott, G.K., Baldwin, M.A., Benz, C.C. Oncogene (1999) [Pubmed]
  6. Expression of a new isoform of the tumor susceptibility TSG101 protein lacking a leucine zipper domain in Burkitt lymphoma cell lines. Ferrer, M., López-Borges, S., Lazo, P.A. Oncogene (1999) [Pubmed]
  7. Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumor-derived human cell lines. Ma, L., Broomfield, S., Lavery, C., Lin, S.L., Xiao, W., Bacchetti, S. Oncogene (1998) [Pubmed]
  8. The products of the yeast MMS2 and two human homologs (hMMS2 and CROC-1) define a structurally and functionally conserved Ubc-like protein family. Xiao, W., Lin, S.L., Broomfield, S., Chow, B.L., Wei, Y.F. Nucleic Acids Res. (1998) [Pubmed]
  9. CROC-1 encodes a protein which mediates transcriptional activation of the human FOS promoter. Rothofsky, M.L., Lin, S.L. Gene (1997) [Pubmed]
  10. Role of UEV-1A, a homologue of the tumor suppressor protein TSG101, in protection from DNA damage. Thomson, T.M., Khalid, H., Lozano, J.J., Sancho, E., Ariño, J. FEBS Lett. (1998) [Pubmed]
  11. The action of caffeine in promoting ultrastructural damage in frog skeletal muscle fibres. Evidence for the involvement of the calcium-induced release of calcium from the sarcoplasmic reticulum. Duncan, C.J., Smith, J.L. Naunyn Schmiedebergs Arch. Pharmacol. (1978) [Pubmed]
  12. Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans. Jung, W.H., Sham, A., White, R., Kronstad, J.W. PLoS Biol. (2006) [Pubmed]
  13. Messenger RNA in dormant cells of Sterkiella histriomuscorum (Oxytrichiade): indentification of putative regulatory gene transcripts. Tourancheau, A.B., Morin, L., Yang, T., Perasso, R. Protist (1999) [Pubmed]
 
WikiGenes - Universities